MedTrace Logo

Carbetocin on Myocardial Repolarization Dynamics in Obstetrics Study

NCT03716076 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2021-05-14

Study results available
· View outcomes & findings →

Summary

Relationship between carbetocin dose on transmural dispersion of repolarization (TDR).

Conditions

  • Cardiac Arrythmias

Interventions

DRUG

Carbetocin

50 mcg or 100 mcg bolus of carbetocin

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Anton Chau, MD MMSc · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2019-06-15
Completion
2020-04-24

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03716076 on ClinicalTrials.gov